Arpida Presents Preclinical Data On AR-2474 At ICAAC

Arpida Ltd (SWX: ARPN) presented several preclinical studies on its novel topical antibiotic AR-2474 at the 47th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago. ICAAC is a major scientific conference where thousands of scientists and clinicians from all over the world gather to discuss the latest developments in the field of infectious diseases. [click link for full article]

More: continued here

Filed under: Clinical Trials on September 25th, 2007